Cognitive decline and brainstem hypometabolism in long-COVID


COVID: A case series: Jacques Hugon, Mathieu Queneau, et. al. Center of Cognitive Neurology, University of Paris, Lariboisière FW Hospital Abstract Objective: To assess FDG cerebral PET in patients suffering…[...]

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches


Roxana Gheorghita1,2Iuliana Soldanescu3Andrei Lobiuc2, et. al. University of Medicine and Pharmacy, Timisoara, Romania The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has been defined as the greatest global health…[...]

Neurological Complications of COVID-19 Infection: A Comprehensive Review


Travis Brauer • Sulaiman Paika • Roshni Kotwani • Deepesh Khanna, 2024, DOI: 10.7759/cureus.65192  Abstract The COVID-19 pandemic is well on its way to reaching endemic status across the globe. While the medical community’s understanding of the…[...]

Cognitive dysfunction in post-COVID-19 condition: Mechanisms, management, and rehabilitation


Marika Möller, Kristian Borg, Christer Janson, Maria Lerm, Johan Normark, Katarina NiwardSeptember 2023, Journal of Internal MedicineVolume 294, Issue 5 p. 563-581 Abstract The long-term effects of COVID-19 on cognitive function have become an area of…[...]

Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain


Héctor Hernández-Parra1,2 Octavio Daniel Reyes-Hernández3 Gabriela Figueroa-González4 Manuel González-Del Carmen5 Maykel González-Torres6 Sheila I. Peña-Corona2 Benjamín Florán7 Hernán Cortés8* Gerardo Leyva-Gómez2* https://pubmed.ncbi.nlm.nih.gov/36998270/ Diverse neurological symptoms have been reported in patients with SARS-CoV-2 disease (COVID-19), including stroke, ataxia, meningitis,…[...]

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside


David Sulzer, Angelo Antonini, Valentina Leta, Anna Nordvig, Richard J. Smeyne, James E. Goldman, Osama Al-Dalahmah, Luigi Zecca, Alessandro Sette, Luigi Bubacco, Olimpia Meucci, Elena Moro, Ashley S. Harms, Yaqian Xu, Stanley Fahn & K. Ray Chaudhuri  npj Parkinson's Disease volume 6, Article number: 18 (2020) Cite this article Abstract This Viewpoint…[...]

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside


David Sulzer, Angelo Antonini, Valentina Leta, Anna Nordvig, Richard J. Smeyne, James E. Goldman, Osama Al-Dalahmah, Luigi Zecca, Alessandro Sette, Luigi Bubacco, Olimpia Meucci, Elena Moro, Ashley S. Harms, Yaqian Xu, Stanley Fahn & K. Ray Chaudhuri  npj Parkinson's Disease volume 6, Article number: 18 (2020) Cite this article Abstract This Viewpoint…[...]

Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review


Authors: Elnaz Khani,aSajad Khiali,aSamineh Beheshtirouy,a and Taher Entezari-Malekia,b,∗ Eur J Pharmacol. 2021 Dec 5; 912: 174582.Published online 2021 Oct 19. doi:  10.1016/ j.ejphar.2021.174582 PMCID: PMC8524700PMID: 34678243 Abstract The acute loss of taste and smell following COVID-19…[...]

Smell and Taste Loss Recovery Time in COVID-19 Patients and Disease Severity


Authors: Athanasia Printza,1,*Mihalis Katotomichelakis,2Konstantinos Valsamidis,1Symeon Metallidis,3Periklis Panagopoulos,4Maria Panopoulou,5Vasilis Petrakis,4 and Jannis Constantinidis1 J Clin Med. 2021 Mar; 10(5): 966.Published online 2021 Mar 2. doi: 10.3390/jcm10050966 PMCID: PMC7957474PMID: 33801170 Abstract A significant proportion of people infected with SARS-CoV-2…[...]

Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae


Authors: Yapeng Su 28, Dan Yuan 28, Daniel G. Chen 28,Mark M. Davis, Jason D. Goldman, James R. Heath 29 Highlights Longitudinal multiomics associate PASC with autoantibodies, viremia and comorbiditiesReactivation of latent viruses during…[...]